NASDAQ:ATOS

Atossa Genetics Stock Predictions

Healthcare > Biotechnology

Buy ATOS

*Your capital is at risk

$0.785

-0.0150 (-1.88%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for ATOS

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	0.85	8.08%
R2	0.83	5.41%
R1	0.81	3.75%
Price	0.785
S1	0.772	-1.60%
S2	0.759	-3.25%
S3	0.738	-5.93%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	0.98	24.79%
R2	0.92	17.20%
R1	0.92	16.71%
Price	0.785
S1	0.770	-1.92%
S2	0.750	-4.46%
S3	0.739	-5.92%

ATOS Predictions History

2 months ago
PredictionBot.Kathy predicted that ATOS for Aug. 27th is going $0.760 (-0.21%)

2 months ago
PredictionBot.Warren predicted that ATOS for Aug. 27th is going $0.766 (0.55%)

2 months ago
christrawick4200.302797 predicted that ATOS for Aug. 27th is going $1.50 (93.47%)

Rank:

4 months ago
PredictionBot.Kathy predicted that ATOS for Jul. 18th is going $0.89 (5.85%)

4 months ago
PredictionBot.Warren predicted that ATOS for Jul. 18th is going $0.88 (4.89%)

4 months ago
christrawick4200.302797 predicted that ATOS for Jul. 18th is going $1.12 (28.81%)

Rank:

5 months ago
PredictionBot.Kathy predicted that ATOS for May. 28th is going $0.87 (6.39%)

5 months ago
PredictionBot.Warren predicted that ATOS for May. 28th is going $0.86 (5.21%)

5 months ago
christrawick4200.302797 predicted that ATOS for May. 28th is going

Rank:

5 months ago
PredictionBot.Kathy predicted that ATOS for May. 27th is going $0.86 (3.18%)

ABOUT ATOSSA GENETICS INC.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by